The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Cost-Effectiveness of Implantable Cardioverter–Defibrillators
Open accessAbstract
BACKGROUND: Eight randomized trials have evaluated whether the prophylactic use of an implantable cardioverter-defibrillator (ICD) improves survival among patients who are at risk for sudden death due to left ventricular systolic dysfunction but who have not had a life-threatening ventricular arrhythmia. We assessed the cost-effectiveness of the ICD in the populations represented in these primary-prevention trials. METHODS: We developed a Markov model of the cost, quality of life, survival, and incremental cost-effectiveness of the prophylactic implantation of an ICD, as compared with control therapy, among patients with survival and mortality rates similar to those in each of the clinical trials. We modeled the efficacy of the ICD as a reduction in the relative risk of death on the basis of the hazard ratios reported in the individual clinical trials. RESULTS: Use of the ICD increased lifetime costs in every trial. Two trials--the Coronary Artery Bypass Graft (CABG) Patch Trial and the Defibrillator in Acute Myocardial Infarction Trial (DINAMIT)--found that the prophylactic implantation of an ICD did not reduce the risk of death and thus was both more expensive and less effective than control therapy. For the other six trials--the Multicenter Automatic Defibrillator Implantation Trial (MADIT) I, MADIT II, the Multicenter Unsustained Tachycardia Trial (MUSTT), the Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) trial, the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial, and the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)--the use of an ICD was projected to add between 1.01 and 2.99 quality-adjusted life-years (QALY) and between 68,300 dollars and 101,500 dollars in cost. Using base-case assumptions, we found that the cost-effectiveness of the ICD as compared with control therapy in these six populations ranged from 34,000 dollars to 70,200 dollars per QALY gained. Sensitivity analyses showed that this cost-effectiveness ratio would remain below 100,000 dollars per QALY as long as the ICD reduced mortality for seven or more years. CONCLUSIONS: Prophylactic implantation of an ICD has a cost-effectiveness ratio below 100,000 dollars per QALY gained in populations in which a significant device-related reduction in mortality has been demonstrated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cost-Effectiveness in Health and Medicine
(1996) · doi:10.1093/oso/9780195108248.001.0001 · Cited by 7,193
Moss, A. J., Zareba, W., Hall, W. J., Klein, H., Wilber, D. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Brown, M. W., & Andrews, M. L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013474 · Cited by 6,902
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., Domanski, M., Troutman, C., Anderson, J., Johnson, G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043399 · Cited by 6,552
Bristow, M. R., Saxon, L. A., Boehmer, J., Krueger, S., Kass, D. A., De Marco, T., Carson, P., DiCarlo, L., DeMets, D., White, B. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032423 · Cited by 5,812
Moss, A. J., Hall, W. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Klein, H., Levine, J. H., Saksena, S., Waldo, A. L., Wilber, D., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352601 · Cited by 4,165
(1997) · New England Journal of Medicine · doi:10.1056/nejm199711273372202 · Cited by 3,232
A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery Disease
Buxton, A. E., Lee, K. L., Fisher, J. D., Josephson, M. E., Prystowsky, E. N., & Hafley, G. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912163412503 · Cited by 2,489
Markov Models in Medical Decision Making: A Practical Guide
Sonnenberg, F. A., & Beck, J. R. (1993) · Medical Decision Making · doi:10.1177/0272989x9301300409 · Cited by 2,419
Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated Cardiomyopathy
Kadish, A., Dyer, A., Daubert, J. P., Quigg, R., Estes, N. A. M., Anderson, K. P., Calkins, H., Hoch, D., Goldberger, J., Shalaby, A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033088 · Cited by 2,080
Connolly, S. J., Gent, M., Roberts, R. S., Dorian, P., Roy, D., Sheldon, R. S., Mitchell, L. B., Green, M. S., Klein, G. J., & O’Brien, B. (2000) · Circulation · doi:10.1161/01.cir.101.11.1297 · Cited by 1,607
Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction
Hohnloser, S. H., Kuck, K. H., Dorian, P., Roberts, R. S., Hampton, J. R., Hatala, R., Fain, E., Gent, M., & Connolly, S. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041489 · Cited by 1,519
Bigger, J. T. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711273372201 · Cited by 1,020
The Markov process in medical prognosis
Beck, J. R., & Pauker, S. G. (1983) · Medical Decision Making · doi:10.1177/0272989x8300300403 · Cited by 957
The Beaver Dam Health Outcomes study: Initial Catalog of Health-state Quality Factors
Fryback, D. G., Dasbach, E. J., Klein, R., Klein, B. E. K., Dorn, N., Peterson, K., & Martin, P. A. (1993) · Medical Decision Making · doi:10.1177/0272989x9301300202 · Cited by 733
Preferences for quality of life or survival expressed by patients with heart failure
Lewis, E. F., Johnson, P. A., Johnson, W., Collins, C., Griffin, L., & Stevenson, L. W. (2001) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(01)00298-4 · Cited by 433
Quality of life in the Canadian Implantable Defibrillator Study (CIDS)
Irvine, J., Dorian, P., Baker, B., O'Brien, B. J., Roberts, R., Gent, M., Newman, D., & Connolly, S. J. (2002) · American Heart Journal · doi:10.1067/mhj.2002.124049 · Cited by 368
Goldman, L. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03460090093039 · Cited by 357
Siebels, J., Kuck, K.-H., & CASH Investigators (1994) · American Heart Journal · doi:10.1016/0002-8703(94)90101-5 · Cited by 232
Zipes, D. P., & Roberts, D. (1995) · Circulation · doi:10.1161/01.cir.92.1.59 · Cited by 231
Stability of Time-tradeoff Utilities in Survivors of Myocardial Infarction
Tsevat, J., Goldman, L., Soukup, J. R., Lamas, G. A., Connors, K. F., Chapin, C. C., & Lee, T. H. (1993) · Medical Decision Making · doi:10.1177/0272989x9301300210 · Cited by 197
Owens, D. K., Sanders, G. D., Harris, R. A., McDonald, K. M., Heidenreich, P. A., Dembitzer, A. D., & Hlatky, M. A. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-1-199701010-00001 · Cited by 186
Self-citationMcClellan, M., & Tunis, S. (2005) · New England Journal of Medicine · doi:10.1056/nejmp048354 · Cited by 153
Gabry, M. D., Brodman, R., Johnston, D. R., Frame, R., Kim, S. G., Waspe, L. E., Fisher, J. D., & Furman, S. (1987) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(87)80477-1 · Cited by 151
Cost-effectiveness of Routine Coronary Angiography After Acute Myocardial Infarction
Kuntz, K. M., Tsevat, J., Goldman, L., & Weinstein, M. C. (1996) · Circulation · doi:10.1161/01.cir.94.5.957 · Cited by 132
Hauser, R. G. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.02.077 · Cited by 121
Larsen, G. C., Manolis, A. S., Sonnenberg, F. A., Beshansky, J. R., Estes, N. A. M., & Pauker, S. G. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90341-j · Cited by 116
Sanders, G. D., Hlatky, M. A., Every, N. R., McDonald, K. M., Heidenreich, P. A., Parsons, L. S., & Owens, D. K. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-10-200111200-00007 · Cited by 86
Self-citationAl‐Khatib, S. M., Sanders, G. D., Mark, D. B., Lee, K. L., Bardy, G. H., Bigger, J. T., Buxton, A. E., Connolly, S. J., Kadish, A. H., Moss, A. J., et al. (2005) · American Heart Journal · doi:10.1016/j.ahj.2005.02.005 · Cited by 73
Self-citationRationale, design and baseline characteristics of the survival and ventricular enlargement trial
Moyé, L. A., Pfeffer, M. A., Braunwald, E., & The SAVE Investigators (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90263-k · Cited by 65
Evidence-Based Medicine And Policy: The Case Of The Implantable Cardioverter Defibrillator
Hlatky, M. A., Sanders, G. D., & Owens, D. K. (2005) · Health Affairs · doi:10.1377/hlthaff.24.1.42 · Cited by 33
Self-citationLife after a ventricular arrhythmia
Hsu, J., Uratsu, C. S., Truman, A. F., Quesenberry, C. P., McDonald, K. M., Hlatky, M. A., & Selby, J. V. (2002) · American Heart Journal · doi:10.1067/mhj.2002.125497 · Cited by 22
Self-citation
Research works printed but not linked: 7
- 2004, Technol Eval Cent Asses Program Exec Summ, 19, 1
- 10.1016/S0735-1097(10)80260-8 · doi:10.1016/s0735-1097(10)80260-8
- Lipscomb J, Weinstein MC, Torrance GW. Time preference. In: Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost effectiveness in health and medicine. New York: Oxford University Press, 1996:214-46.
- 10.1016/0735-1097(95)80013-7 · doi:10.1016/0735-1097(95)80013-7
- Every NR, 1997, Circulation, 96, 1770, 10.1161/01.CIR.96.6.1770 · doi:10.1161/01.cir.96.6.1770
- 10.1001/jama.265.9.1145 · DOI
- 10.1016/j.ahj.2004.12.001 · doi:10.1016/j.ahj.2004.12.001
Cited by
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab670 · Cited by 19,442
2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab368 · Cited by 13,344
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.592 · Cited by 5,866
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001063 · Cited by 4,922
Metadata
- Authors
- Sanders, G. D., Hlatky, M. A., & Owens, D. K.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-10-06
- Volume
- 353
- Issue
- 14
- Pages
- 1471-1480
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2000325901
- Cited by
- 547
- References
- 31
- FWCI
- 30.33
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.